Ballentine Partners’s Haleon HLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Sell
33,797
-9,480
-22% -$88.1K ﹤0.01% 770
2026
Q1
$433K Buy
43,277
+6,728
+18% +$70K 0.01% 583
2025
Q4
$370K Buy
36,549
+14,191
+63% +$135K 0.01% 622
2025
Q3
$201K Sell
22,358
-11,777
-35% -$113K ﹤0.01% 920
2025
Q2
$354K Buy
34,135
+4,515
+15% +$47.6K 0.01% 619
2025
Q1
$305K Buy
29,620
+2,659
+10% +$26.2K 0.01% 622
2024
Q4
$257K Buy
26,961
+4,130
+18% +$40.4K ﹤0.01% 660
2024
Q3
$242K Buy
22,831
+7,918
+53% +$76.6K ﹤0.01% 673
2024
Q2
$123K Sell
14,913
-1,531
-9% -$12.8K ﹤0.01% 717
2024
Q1
$140K Sell
16,444
-1,075
-6% -$8.98K ﹤0.01% 697
2023
Q4
$144K Sell
17,519
-3,574
-17% -$29.5K ﹤0.01% 640
2023
Q3
$176K Sell
21,093
-375
-2% -$3.12K ﹤0.01% 554
2023
Q2
$180K Sell
21,468
-1,974
-8% -$16.8K ﹤0.01% 558
2023
Q1
$191K Buy
23,442
+343
+1% +$2.73K ﹤0.01% 527
2022
Q4
$185K Buy
23,099
+5,736
+33% +$39K 0.01% 470
2022
Q3
$106K Buy
+17,363
New +$112K ﹤0.01% 457

Other funds holding HLN

Ballentine Partners's HLN Position: Q2 2026 in Review

Ballentine Partners reduced its Haleon (HLN) stake by 22% in Q2 2026, selling an estimated $88.1K and leaving 33,797 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #770.

Ballentine Partners first reported a position in HLN in Q3 2022 and has held it in 16 quarters since. The position peaked at $433K in Q1 2026. 641 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • Ballentine Partners held 33,797 shares of Haleon worth $315K as of Q2 2026.
  • Ballentine Partners sold 9,480 Haleon shares in Q2 2026, an estimated $88.1K.
  • Haleon made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #770 holding.
  • Ballentine Partners first reported a position in Haleon in Q3 2022 and has held it in 16 quarters since.
  • Ballentine Partners's Haleon position peaked at $433K in Q1 2026.
  • 641 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.